Scientific PostersRespiratory Drug Delivery (RDD®) invites you present your research relating to pulmonary and nasal delivery in the Scientific Poster Session at Respiratory Drug Delivery 2018. The abstract deadline is January 8, 2018. Your abstract will be published in the Conference Proceedings and be seen by researchers worldwide via RDD’s searchable online database.

Accepted abstracts from graduate students are automatically eligible for the VCU RDD Peter R. Byron Graduate Student Award which covers the student's registration fee, travel expenses and accommodation up to a maximum of $2000.

RDD 2018 will feature “Posters on the Podium (PoP)” where our team of reviewers select poster presenters with interesting, important or innovative topics to deliver a ten-minute summary of their work in the main auditorium followed by a fast-paced Q&A session. Every abstract we receive is automatically considered for Posters on the Podium.

The Scientific Poster Session is held in conjunction with the Technology Exhibition to promote scientific discussion and networking and will be continuously accessible from 10:00 AM until 7:00 PM on Monday, April 23, and from 8:30 AM to 7:00 PM on Tuesday, April 24, while the meeting is in session. All posters are exhibited throughout both days. The Scientific Poster Session and Technology Exhibition will be the main RDD event during the following times:

  • Monday, April 23, 11:30 AM–2:30 PM and 5:00–7:00 PM
  • Tuesday, April 24, 11:30 AM–2:30 PM and 5:00–7:00 PM

 

Poster Abstracts Received

Organization Primary Author and Poster Title Status Copyright
Alex Slowey
In-situ Assessment Of pMDI Solution Stability Using Computed Tomography
Abstract Received and In Review
ACG
Fernando Diez
Mapping Perfomance Of Inhalation Based Capsules With Appropriate Puncturing For Optimum Dose Delivery
Abstract Received and In Review
Aston Particle Technologies
Jasdip Koner
Early Experience In The Development And Use Of A Novel Blending Technology For DPI Formulation
Abstract Received and In Review
AstraZeneca
Jan Olof Svensson
Fully Automated Delivered Dose Uniformity And Fine Particle Dose Testing Of Dry Powder Inhalers – Analytical Principles Using Uplc With UV- And MS-Detection
Abstract Received and In Review
AstraZeneca
Jan Olof Svensson
Comparison Of Aerodynamic Particle Size Distribution For Symbicort pMDI 80/2.25 When Tested Using The Andersen Cascade Impactor And Either USP 23 Or USP 35 Inlets
Abstract Received and In Review
AstraZeneca
Jan Olof Svensson
In-vitro Characterization Of Symbicort pMDI In Combination With Aerochamber Plus Flow-vu® And Aerochamber Plus® Spacers
Abstract Received and In Review
Auckland University of Technology
Sandra Grau-Bartual
Effect Of Positive Airway Pressure (PAP) On Human Nasal And Bronchial Epithelial Cells
Abstract Received and In Review
Celon Pharma
Ewa Tratkiewicz
Ketamine High Dose Dry Powder Composition For Pulmonary Administration
Abstract Received and In Review
CF PharmTech
Jean-Marc Bovet
Particle Shape, Surface Roughness And Crystal Habit As Mean To Asses Formulated API’s Stability In HFA pMDI
Abstract Received and In Review
Chiesi Farmaceutici
Andrea Benassi
Characterization Of Active Powder Dissolution Time For Manufacturing Unit Operations
Abstract Received and In Review
Christian Albrecht University of Kiel
Judith Heidland
Nano-in-microparticles For Dry Powder Vaccination – Nasal Application And Uptake In Immune Competent Cells
Abstract Received and In Review
Christian Albrecht University of Kiel
Angelika Jüptner
Spray Dried Formulations For Nasal Applications – Challenges And Opportunities In Filling And Drug Delivery
Abstract Received and In Review
Christian Albrecht University of Kiel
Nancy Rhein
Influence Of Drug Concentration On Dry Powder Inhaler Formulations Based On A Mannitol And A Lactose Carrier System
Abstract Received and In Review
Chungbuk National University
Ji-Hyun Kang
Computational Fluid Dynamics (CFD) And Particle Image Velocimetry (PIV) Investigation Of Dry Powder Aerosolization Of Bosentan Microparticles According To The Spiral Mouthpiece
Returned for Revision
Chungbuk National University
Hyo-Jung Lee
Inhalable Spray-Dried Bosentan Microparticles In The Treatment Of Monocrotaline-Induced Pulmonary Hypertension In Rats
Abstract Received and In Review
CSP Technologies
Gary Peters
Characterization Of Desiccant Moisture Adsorption Capacity Required For A New Dry Powder Inhaler Design
Abstract Received and In Review
Gerald Hebbink
Round Robins Of A Particle Sizing Method Of A Dry Powder Inhalation Carrier
Abstract Received and In Review
Drinker Biddle & Reath
Svetlana Lyapustina
The Future Is Suddenly Here: Legal And Regulatory Considerations For Digital Health Apps And Inhalers
Abstract Received and In Review
Drinker Biddle & Reath
Lee Nagao
Plume Geometry Testing Relevance And Methodology: An IPAC-RS Survey
Abstract Received and In Review
Gateway Analytical
Angela Flowers
Analysis Of A Dry Powder Inhaler API Using Scanning Electron Microscopy
Returned for Revision
Grifols
Angela Davis
Compliance With Once-daily Inhaled Liposomal Ciprofloxacin (ARD-3150) Therapy In Non-Cystic Fibrosis Bronchiectasis
Abstract Received and In Review
Andrew Newman
Achieving High Performance Across Patient Flow Rates From An Innovative Capsule-based Dry Powder Inhaler (DPI)
Abstract Received and In Review
Harro Höfliger Verpackungsmaschinen
Karlheinz Seyfang
100% In-line Mass Verification Of Powder Dose In DPI Blister And DPI Discs Using X-ray
Abstract Received and In Review
Hovione
Diana Fernandes
Studying The Impact Of Spray Drying On A Model Enzyme Intended For A Dry Powder Inhaler Formulation
Abstract Received and In Review
Hovione
Beatriz Noriega
Collecting The Biorelevant Aerosol Fraction For Dissolution Testing Of Orally Inhaled Drugs: Adding A Newly Designed Pre-separator To Preciseinhale®
Abstract Received and In Review
Hovione
Beatriz Noriega
Dissolution Of Orally Inhaled Drugs Using Paddle Over Disk Apparatus: A Deposition Study
Abstract Received and In Review
InAMed
Wolfgang Timmer
Particularities Of The Development Of Inhaled Drug Products
Abstract Received and In Review
Inhalation Sciences Sweden
Maria Malmlöf
A Comparison Of Dissolvit Dissolution Profiles Of Particles Deposited With A New Generation Impactor or With A Preciseinhale Aerosol Generator
Returned for Revision
David Gomez-Lamarca
Process For Reducing Amorphous Content On Micronized Indacaterol Maleate For Dry Powder Inhaler Formulations
Abstract Received and In Review
David Gomez-Lamarca
Comparative Stability Studies Between Air Jet Micronized And Wet Milled Glycopyrronium Bromide Towards Humidity
Abstract Received and In Review
Lovelace Biomedical
Philip Kuehl
Inhalation Delivery Of Aerosolized Topotecan – Formulation Development And In Vivo Pharmacokinetics
Abstract Received and In Review
Mirjam Kobler
Influence Of Storage Conditions On Micronized Lactose And The Resulting Ternary Dry Powder Inhaler Formulations
Abstract Received and In Review
Merck
Balaji Bharatwaj
Rapid Development Of A Solution Metered Dose Inhaler Formulation For A Pan-Janus Kinase (JAK) Inhibitor For The Treatment Of Severe Asthma
Returned for Revision
Mexichem UK Limited
Stuart Corr
Compatibility Of P152a With Pressurized Metered Dose Inhaler Device Materials
Returned for Revision
Microbase Technology
Chang-wei Chou
A Novel Contact-Triggered Vibrating-Mesh Nebulizer-SMI: Nebulization Performance And Total Inhaled Dose Of Suspension Drug
Abstract Received and In Review
MVIC AB - Medicon Valley Inhalation Consortium
Lars Asking
Pressurized Metered Dose Inhalers (pMDIs) And The Slow Inhalation Recommendation
Abstract Received and In Review
Oz-UK Ltd
Rob Johnson
Determination Of Viscosity In Ethanol And HFA 134a Mixtures
Abstract Received and In Review
Oz-UK Ltd
Rob Johnson
Determination Of Density And Surface Tension In Ethanol And HFA 134a Mixtures
Abstract Received and In Review
PA Consulting Group
Kian Min Lim
Robust Characterisation Of Inhalation Information Using Deep Neural Network And A Smartphone
Abstract Received and In Review
Philip Morris International
Mahdi Asgari
Multispecies Liquid Particles Evolution And Deposition In A Respiratory Tract Model
Abstract Received and In Review
Philips Respironics
Ross Hatley
Dose Inconsistency Through Pressurized Metered Dose Inhaler Canister Life
Abstract Received and In Review
Philips Respironics
John Pritchard
Dose Consistency From A Mesh Nebulizer Over A Range Of Peak Inhalation Flows
Abstract Received and In Review
Heli Chauhan
Impact Of Actuator Design On Multi Dose Nasal Spray Characteristics
Returned for Revision
Purdue University
Tony Zhou
Spray Dried Amorphous DPI Formulations: Role Of Excipients on Physical Stability And Aerosol Performance
Returned for Revision
Purdue University
Tony Zhou
Impact Of Crystallization On Physical Stability And Aerosol Performance Of Spray Dried Ciprofloxacin Powder Formulation
Returned for Revision
Research Triangle Institute
Ian Stewart
Nebulized Immunoglobulin Aerosol Characterization Toward Reinforcement Of Airway Mucosal Defense Against Pathogens
Abstract Received and In Review
S5 Consulting
Dennis Sandell
Estimation Of Stage Cut-offs For The Next Generation Impactor (NGI) When Used At Flow Rates Above 100 L/min
Abstract Received and In Review
Scientific Consultant
Henry Chrystyn
In-vitro Assessment Of A Novel Integrated Electronic Multidose Dry Powder Inhaler
Abstract Received and In Review
Scientific Consultant
Jolyon Mitchell
Utopia! Why Can’t Pharmacopeias Agree?
Abstract Received and In Review
State University of New York
Gerald Smaldone
Nebulized Mannitol And Cough In Idiopathic Pulmonary Fibrosis
Abstract Received and In Review
Technical University of Braunschweig
Andreas Dietzel
A Comparison Of Product Carbon Footprints Of Respimat® Versus Pressurized Metered-dose Inhalers
Abstract Received and In Review
Trudell Medical International
Jason Suggett
How Many Inhalations Does It Take To Empty A Valved Holding Chamber? – An Experimental Investigation
Abstract Received and In Review
Trudell Medical International
Jason Suggett
A Laboratory Investigation Into The Performance Of A Valved Holding Chamber (VHC) With The Respimat® Soft Mist Inhaler (SMI), Using An Adult Oropharynx Model And Breathing Simulation
Abstract Received and In Review
Université de Tours
Laurent Vecellio
Nasal Drug Delivery By Oral Route Using A pMDI: Influence Of Particle Size And Expiratory Flow Rate
Returned for Revision
University College London
Shraddha Ghodke
Design And Development Of Hyaluronic Acid Coated Chitosan Based Curcumin Loaded Nano Carriers For Targeted Pulmonary Delivery
Returned for Revision
James Ivey
An In-silico Investigation Of Formulation And Device Effects On The Aerodynamic Particle Size Distributions Of Suspension Pressurized Metered Dose Inhalers
Abstract Received and In Review
James Ivey
Isokinetic In-line Sampling Enables Rapid Characterization Of Atomizers And Cyclones For Spray Drying Process Development
Received by Publisher
Reinhard Vehring
Interaction Of Evaporating Multicomponent Microdroplets With Humid Environments
Received by Publisher
Reinhard Vehring
Monodisperse Droplet Chain Technique To Support Development Of Co-solvent Based Inhalation Products
Received by Publisher
Hui Wang
A New Shadowgraphic Imaging Method For The Suspension Stability Analysis Of Pressurized Metered Dose Inhalers
Abstract Received and In Review
University of Oklahoma
Sevim Hatipoglu
Inhalable Clofazimine Nanocrystals For Tuberculosis Treatment
Abstract Received and In Review
University of Parma
Adryana Clementino
Lecithin/Chitosan-based Nanoparticles For The Nasal Delivery Of Statins: Enzyme-trigger Controlled Release And Cellular Transport
Abstract Received and In Review
University of Parma
Irene Rossi
Sodium Hyaluronate Microparticles For Pulmonary Delivery Of Anti-Mycobacterial Drugs
Abstract Received and In Review
University of Sydney
Yoon Kyung (Rachel) Chang
Antibacterial Activities Of Dry Powder Phage Formulation Against Multidrug Resistant Bacteria In Mouse Lung Infection Model - A Proof-of-Principle Study
Abstract Received and In Review
University of Texas at Austin
Silvia Ferrati
A Systematic Analysis of the Effect of Formulation Parameters on the Aerosol Performance and Stability of Aerosol Performance and Stability of Spray Freeze Dried Protein Powders
Returned for Revision
University of Texas at Austin
Daniel Moraga-Espinoza
Influence Of Airflow On Plume Geometry Of Commercially Available Suspension pMDIs Using Mass-based Plume Analysis
Returned for Revision
University of Texas at Austin
Daniel Moraga-Espinoza
Influence of Airflow on Plume Geometry of a Solution pMDI Using a Mass-Based Plume Angle Analysis
Returned for Revision
University of Utah
Tatjana Bevans-Warren
Inhaled Remifentanil In A Porcine Model
Abstract Received and In Review
Mandana Azimi
Development And Characterization Of A Ciprofloxacin Nanocomposite Dry Powder Formulation For Targeted Nasal Delivery
Abstract Received and In Review
Susan Boc
Aerosolization Of Spray Dried Pulmonary Surfactant Powder Using A Novel Low Air Volume Actuated Dry Powder Inhaler
Abstract Received and In Review
Susan Boc
Spray Dried Pulmonary Surfactant Powder Formulations: Development And Characterization
Abstract Received and In Review
Sneha Dhapare
Breath-synchronized Delivery Of Aerosols To Infants Using A Very Low Volume Mixer-heater
Abstract Received and In Review
Dale Farkas
Efficient Delivery Of A Dry Powder Aerosol Through A Low Flow Nasal Cannula System
Abstract Received and In Review
Masahiro Sakagami
In Vitro Transwell Dish-based Dissolution Testing For Inhaled Corticosteroid (ICS) Products
Abstract Received and In Review
Benjamin Spence
Optimization Of A Combination Device For High Efficiency Aerosol Delivery And High Flow Nasal Cannula Therapy
Abstract Received and In Review
Warsaw University of Technology
Tomasz Sosnowski
Physicochemical Assessment Of Nanoparticle Impact On The Pulmonary Surfactant By Oscillation Drop Method
Abstract Received and In Review
Woolcock Institute of Medical Research
Hui Xin Ong
Inhaled Liposomal Ciprofloxacin Nanoparticles For The Treatment Of Respiratory Biofilm Infections
Abstract Received and In Review
Woolcock Institute of Medical Research
Jesse Xu
Determination Of Biocompatible And Mechanical Suitability Of 3D-Printable Materials For Use In A Personalized Airway Stent
Returned for Revision

Preparing a Poster Abstract for Submission

Respiratory Drug Delivery has a track record of producing high-quality abstracts for distribution to conference participants at the meeting. To ensure the maximum chance of poster acceptance:

  • Write your abstract using simple scientific language to describe recent experiments, innovations and insights
  • Include data, new concepts or approaches
  • Ensure that all claims and conclusions are supported by data or references, especially those making comparisons to competing products
  • Please do not submit work that has been presented at other meetings. However, your are welcome to send us work that builds on previous presentations

Poster abstracts should be submitted in Microsoft Word and be 3 to 5 pages long, when printed double-spaced using Arial 12 point font. Prepare your poster abstract according to the Poster Abstract Guidelines.

The Publication Process

  • Our review team will evaluate your poster paper and let the primary author know by e-mail if it has been accepted for presentation at RDD 2018 between January 18 and February 15, 2018. Reviewers may accept, reject or request modifications to poor-quality papers. If accepted, please make any requested corrections or alterations within 7 days.
  • Obtain Copyright Permission from the original publisher to use any copyrighted materials that appear in your poster paper.
  • Send revised electronic copies of your final poster abstract to Richard Dalby and Jill Cone. February 19, 2018, is the absolute deadline for receipt of revised poster papers.
    Richard N. Dalby, Ph.D.
    Phone: +1 (410) 706-3245
    Email: rdalby@rx.umaryland.edu
    Jill Cone
    Phone: +1 (919) 858-9400
    Email: jtcone@earthlink.net
  • Send a signed Transfer of Copyright Form to Respiratory Drug Delivery by email by February 19, 2018. We are required by the Virginia Commonwealth University Intellectual Property Foundation to obtain and keep on file a signed Transfer of Copyright Form for all articles published in the RDD Proceedings. Authors retain the right to use the content of their articles as they see fit and usually extend their work into full manuscripts. The Copyright Transfer requests that you ask permission to reproduce (we have always granted permission upon request) and that you acknowledge RDD. 
  • The Publisher will typeset your abstract and email Acrobat (.pdf) proofs for you to correct. You should return the proofs by email within 48 hours of receipt. Please make typographical corrections only; it’s too late to change the text!

Poster Session Guidelines

The scientific poster session is designed to offer you and your organization the opportunity to display innovative research and technology of interest to the aerosol community. This session is extremely flexible, but you should adhere to the following guidelines.

Poster Boards

Poster

We will assign a display location with the dimensions shown in the diagram. Your poster can be attached to the board with Velcro or pins which we supply. The skirted, shared table beneath your poster is intended to allow distribution of copies of your poster, business cards and other literature. It also facilitates demonstrations of small handheld devices or holds a laptop, but is unsuitable for anything heavier than 10 lbs. Poster displays do not have access to electricity.

Making an Impact

Posters provoke the most discussion when you follow three simple rules:

  • Make the text large and legible. We recommend a dark colored font, readable at six feet.
  • Focus on one or two essential themes and emphasizes novel findings.
  • Keep the overall design simple, but include legible, diagrams, tables and figures.

Poster Session Etiquette

Poster content must be closely related to your published abstract. All claims and conclusions must be supported by data or references. Do not include speculative or unsubstantiated comments.

The major attraction of a poster is its presenter! Please be present at your poster to answer questions for at least an hour each time the Scientific Poster Session is open. If you don’t plan to stay the whole time, it’s helpful to display a sign showing the times you plan to be present. Person-to-person delegate messaging will be available via the RDD 2018 Conference website to encourage discussion and networking.

Set-Up

Do not attempt to enter the exhibition area before 3:00PM on Sunday, April 22. Set-up is encouraged on Sunday, April 22, between 3:00–7:00 PM, but for late arrivals, set-up is permitted on Monday, April 23, from 7:30–9:00 AM.

After you visit the on-site registration desk, review the conference program or the floor plan in the exhibition area to find your assigned display location. Do not set up in a different location. To protect your property, hotel security will not allow access to the exhibition area from Sunday at 7:00 PM until Monday at 7:30 AM.

Scientific Poster and Technology Exhibition Floor Plan will be provided to all registrants of the conference with Poster Numbers clearly labeled. To assist poster presenters in finding their assigned location, each empty poster board will be clearly labeled.

Take Down

Posters should be removed between 7:00–9:00 PM on Tuesday, April 24. At your own risk you may remove your poster on Wednesday, April 25, between 7:30 AM–9:30 AM, but please note there will be no hotel security on Tuesday night. Posters not removed before 9:30 AM Wednesday could be lost or damaged as the exhibition is dismantled.

The Small Print

The meeting organizers and the JW Marriott Starr Pass Resort expressly disclaim responsibility for loss or damage to posters, laptops and other items that you bring into the exhibition. We recommend that you take small, high value items such as laptop computers or prototype devices with you when you are not at your poster or when leaving the exhibition for the evening.

Shipping Instructions

Please ensure anyone shipping packages to the meeting on your behalf receives a copy of these instructions.

Hotel Shipping & Receiving Contact Information

Jarod Peterson

TEL: (+1) 520 791-6200

EMAIL: store6350@theupsstore.com

Shipping Schedule

Packages to the Starr Pass Resort and Spa should be timed to arrive between April 17 and April 20, 2018. Packages arriving on Monday, April 16, 2018, or earlier will incur a fee. Packages will be brought to your exhibit table or poster.

Main Label for Your Shipment

RDD registrant staying at the resort:
JW Marriott Starr Pass Resort & Spa
ATTN: Hotel Guest Name, Arrival Date
RDD 2018 Conference; RDD Contact R. Dalby
3800 W Starr Pass Blvd, Tucson, AZ 85745
Phone: +1 520-791-6200

RDD registrant not staying at the resort:
JW Marriott Starr Pass Resort & Spa
ATTN: Dr. Richard Dalby, RDD 2018
RDD 2018 Conference, RDD Registrant Name
3800 W Starr Pass Blvd, Tucson, AZ 85745
Phone: +1 520-791-6200

Auxiliary Label for Your Shipment

  • Include your name, your company name (not just shipper’s name) and the purpose of the box contents (e.g., Poster, Exhibit Table, Reception).
  • Ensure that your company’s return address or that of your shipping company is clearly displayed on the outer box.
  • Number each box and the total number of boxes in your shipment (e.g., Box 1 of 3, Box 2 of 3, Box 3 of 3).

For Packages Coming from Outside the US:

Contact your shipper for specific instructions. The following is a guide based on past experience. Neither the conference nor hotel is responsible for lost or delayed shipments.

  • Anticipate the possibility of inspection by US Customs and allow sufficient time for customs clearance.
  • Elect to have import duties or taxes billed directly to your company on paperwork.
  • Include an International Waybill and Commercial Invoice. The declared value should be the same on both forms.
  • State explicitly on customs paperwork “Items for demonstration—Respiratory Drug Delivery Conference, April 22-26, 2018, JW Marriott Starr Pass Resort & Spa —and re-export thereafter. Items to be shipped back April 26, 2018”
  • At the same time you send your package(s), email the Resort’s Shipping Department, at store6350@theupsstore.com to let them know to expect your shipment.
  • When sending your package home after the meeting, include this statement on the label: “Re-export and return of Items from RDD Conference, Apr 22-26, 2018, JW Marriott Starr Pass Resort & Spa”.

For all packages:

  • Package fragile items carefully and include a packing list inside and outside each box. Include pre-printed return shipping forms (including Commercial Invoice and International Waybill for overseas shipments) and a roll of tape to seal boxes for the return shipping.
  • You are responsible for organizing the packing and outgoing shipment of your materials. The hotel will have blank shipping forms and labels available for most large carriers. We suggest you know and use your own carrier account number for your outgoing shipment.
  • When the resort imposes Shipping and Receiving Charges these are the responsibility of the sender. Incoming package fees may be charged to a hotel guest room. Outgoing fees and fees for delegates staying off-property must be billed to a credit card.
  • No COD shipments.

Questions?

For further information, contact Richard Dalby.

Back to Top